Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropria...

Full description

Saved in:
Bibliographic Details
Published inBMC gastroenterology Vol. 25; no. 1; pp. 421 - 9
Main Authors Zhu, Huiling, Zheng, Mengyao, Li, Wenbin, Huang, Yaqin, Zhang, Lili, Yang, Wenting, Yang, Jinhui
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 30.05.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.
AbstractList Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.BACKGROUNDPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.METHODSA total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).RESULTSIn our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.CONCLUSIONSCPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.
BackgroundPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear.MethodsA total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan–Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients.ResultsIn our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003–1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018–1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009–1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan–Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05).ConclusionsCPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.
Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. Methods A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan-Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. Results In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003-1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018-1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009-1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan-Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). Conclusions CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients. Keywords: Primary biliary cholangitis, CPNI, Prognosis
Abstract Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with malabsorption of fat-soluble vitamins and osteoporosis. Thus, evaluating the nutritional status of patients with PBC and implementing appropriate interventions are significant. But CPNI in determining the nutritional status and forecasting survival outcome among patients with PBC remains unclear. Methods A total of 262 patients with PBC were retrospectively enrolled at the Second Affiliated Hospital of Kunming Medical University between January 2013 and November 2023. We used the receiver operating characteristic (ROC) curve, Kaplan–Meier survival curve, and logistic regression analysis to evaluate the predictive effects of several nutritional assessments. These assessments included the controlling nutritional status (CONUT), geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and Cholesterol-modified Prognostic Nutritional Index (CPNI), which were evaluated for their predictive effect on the prognosis of PBC patients. Results In our study, after adjusting for various confounding factors, multivariate cox regression analyses revealed that CPNI (HR: 1.114, 95% CI: 1.003–1.237, P = 0.044), age (HR: 1.071, 95% CI: 1.018–1.127, P < 0.009), total bilirubin (HR:1.019, 95% CI:1.009–1.09, P < 0.001) were independent risk factors for death in patients with PBC. The Kaplan–Meier curves and ROC curves used to assess predictive accuracy showed that CPNI(0.788) had superior prognostic performance for OS compared to other nutritional indices, such as CONUT(0.724), GNRI(0.755), PNI(0.776), and UK-PBC(0.660)(P < 0.05). Conclusions CPNI is superior to other nutritional scores in the prognostic assessment of PBC patients.
ArticleNumber 421
Audience Academic
Author Zhang, Lili
Zheng, Mengyao
Li, Wenbin
Yang, Wenting
Yang, Jinhui
Zhu, Huiling
Huang, Yaqin
Author_xml – sequence: 1
  givenname: Huiling
  surname: Zhu
  fullname: Zhu, Huiling
– sequence: 2
  givenname: Mengyao
  surname: Zheng
  fullname: Zheng, Mengyao
– sequence: 3
  givenname: Wenbin
  surname: Li
  fullname: Li, Wenbin
– sequence: 4
  givenname: Yaqin
  surname: Huang
  fullname: Huang, Yaqin
– sequence: 5
  givenname: Lili
  surname: Zhang
  fullname: Zhang, Lili
– sequence: 6
  givenname: Wenting
  surname: Yang
  fullname: Yang, Wenting
– sequence: 7
  givenname: Jinhui
  surname: Yang
  fullname: Yang, Jinhui
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40448036$$D View this record in MEDLINE/PubMed
BookMark eNptkkmP1DAQhSM0iFngD3BAkbhwyeDyFueERi2WkUbiAhI3y-2lx03abuz0CG78dKoXRt0IRYqdyudXeZV32ZylnHzTvARyDaDk2wpU9bIjVHSEE2CdetJcAO-ho4x8OzvanzeXtS4JgV5R9qw554RzRZi8aH7P7vPo6-RLHrtVdjFE79p1yYuU6xRtmzZTiVPMyYxtTM7_bE1tTdrt1x5vaTrG5zGvTPnuCwJYj_jwC4tj3K4We5m0QLnars0U8Wx93jwNZqz-xWG9ar5-eP9l9qm7-_zxdnZz11kB_dTxwYY5FcIAGYhyA5XOghEBiPCCMwnMck8c55QpSkAqB8MQuJv3TsyDUeyqud3rumyW-vBlOpuod4VcFtoUdDB6LYOnwRPjPPEcBz2YoEBaJwMT3sketd7ttdab-co7iz6KGU9ET9-keK8X-UEDBSoUkajw5qBQ8o8Nzl-vYrV-xPH4vKmaUeAMJB-2zV7_gy7zpuDv2FFSCDWwI2ph0EFMIWNjuxXVN4pTCqJXAqnr_1B4Ob-KFtMVItZPDrw6dvpo8W-AEKB7wJZca_HhEQGitynV-5RqTKnepVQr9geieNuo
Cites_doi 10.21873/invivo.11430
10.1016/S2468-1253(19)30343-7
10.1136/flgastro-2018-101109
10.1016/j.jhep.2017.03.022
10.1080/14656566.2019.1601701
10.3390/nu14142823
10.1002/jcsm.12980
10.1016/j.mam.2007.09.009
10.1038/s41598-018-30906-8
10.1080/07853890.2019.1693056
10.32074/1591-951X-245
10.1016/j.dld.2022.12.010
10.1002/hep.1840110324
10.1016/j.cgh.2024.01.039
10.1093/ajcn/82.4.777
10.1186/s12877-020-1501-8
10.1016/S0140-6736(24)01303-5
10.3390/biomedicines10123046
10.5582/bst.2024.01108
10.1186/s12916-023-03225-7
10.3390/ijms21155357
10.17116/terarkh20178912216-225
10.3390/nu15092014
10.1155/2021/9151525
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12876-025-04013-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database

MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-230X
EndPage 9
ExternalDocumentID oai_doaj_org_article_6fe2fe0ade0e41869af816cd6f35ed67
PMC12125806
A842215785
40448036
10_1186_s12876_025_04013_8
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: the National Natural Science Foundation of China
  grantid: 82160106
– fundername: Second Affiliated Hospital of Kunming Medical College, China
  grantid: ynllT2021001, ynllT2021009
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7QR
7T5
7XB
8FD
8FK
AZQEC
DWQXO
FR3
H94
K9.
M48
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c517t-49cfb255a10908d926dc1a5f105e543613c4e0d4423820168d199f4db7d5bfa83
IEDL.DBID 7X7
ISSN 1471-230X
IngestDate Wed Aug 27 01:26:03 EDT 2025
Thu Aug 21 18:36:40 EDT 2025
Fri Jul 11 17:11:05 EDT 2025
Fri Jul 25 09:29:18 EDT 2025
Tue Jun 17 21:58:53 EDT 2025
Tue Jun 17 03:41:35 EDT 2025
Tue Jun 03 01:34:04 EDT 2025
Wed Aug 20 07:45:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Primary biliary cholangitis
Prognosis
CPNI
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-49cfb255a10908d926dc1a5f105e543613c4e0d4423820168d199f4db7d5bfa83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3216558937?pq-origsite=%requestingapplication%
PMID 40448036
PQID 3216558937
PQPubID 44673
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_6fe2fe0ade0e41869af816cd6f35ed67
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12125806
proquest_miscellaneous_3214316497
proquest_journals_3216558937
gale_infotracmisc_A842215785
gale_infotracacademiconefile_A842215785
pubmed_primary_40448036
crossref_primary_10_1186_s12876_025_04013_8
PublicationCentury 2000
PublicationDate 2025-05-30
PublicationDateYYYYMMDD 2025-05-30
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-30
  day: 30
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC gastroenterology
PublicationTitleAlternate BMC Gastroenterol
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 4013_CR2
K Chen (4013_CR14) 2024; 18
S Kushiyama (4013_CR12) 2018; 32
European Association for the Study of the Liver (4013_CR13) 2017; 67
4013_CR7
4013_CR8
L Jopson (4013_CR21) 2015; 33
AA Gossard (4013_CR26) 2019; 20
P Muratori (4013_CR18) 2008; 29
F Meyer (4013_CR23) 2020; 21
VI Reshetnyak (4013_CR20) 2022; 10
P Gentileschi (4013_CR15) 2022; 14
A Tanakai (4013_CR1) 2024; 404
SB Heymsfield (4013_CR24) 1990; 11
S Sarcognato (4013_CR19) 2021; 113
L Zheng (4013_CR5) 2024; 22
J Gazda (4013_CR3) 2021; 2021
4013_CR22
J Gazda (4013_CR6) 2023; 55
4013_CR27
S Prausmüller (4013_CR16) 2022; 13
Y Zhao (4013_CR17) 2020; 20
H Takahashi (4013_CR28) 2023; 15
L Li (4013_CR11) 2018; 8
J Shi (4013_CR10) 2023; 21
RA Shah (4013_CR25) 2020; 5
JC Goet (4013_CR4) 2019; 10
L Sun (4013_CR29) 2019; 51
O Bouillanne (4013_CR9) 2005; 82
References_xml – volume: 32
  start-page: 1667
  year: 2018
  ident: 4013_CR12
  publication-title: In Vivo
  doi: 10.21873/invivo.11430
– volume: 5
  start-page: 306
  year: 2020
  ident: 4013_CR25
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(19)30343-7
– volume: 10
  start-page: 316
  year: 2019
  ident: 4013_CR4
  publication-title: Frontline Gastroenterol
  doi: 10.1136/flgastro-2018-101109
– volume: 67
  start-page: 145
  year: 2017
  ident: 4013_CR13
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.03.022
– volume: 20
  start-page: 1161
  year: 2019
  ident: 4013_CR26
  publication-title: Expert Opin Pharmacother
  doi: 10.1080/14656566.2019.1601701
– volume: 33
  start-page: 109
  issue: Suppl 2
  year: 2015
  ident: 4013_CR21
  publication-title: Pathogenesis and Management Dig Dis
– volume: 14
  start-page: 2823
  year: 2022
  ident: 4013_CR15
  publication-title: Nutrients
  doi: 10.3390/nu14142823
– volume: 13
  start-page: 1477
  year: 2022
  ident: 4013_CR16
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12980
– volume: 29
  start-page: 96
  year: 2008
  ident: 4013_CR18
  publication-title: Mol Aspects Med
  doi: 10.1016/j.mam.2007.09.009
– volume: 8
  start-page: 12561
  year: 2018
  ident: 4013_CR11
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-30906-8
– volume: 51
  start-page: 333
  year: 2019
  ident: 4013_CR29
  publication-title: Ann Med
  doi: 10.1080/07853890.2019.1693056
– volume: 113
  start-page: 170
  year: 2021
  ident: 4013_CR19
  publication-title: Pathologica
  doi: 10.32074/1591-951X-245
– volume: 55
  start-page: 1318
  year: 2023
  ident: 4013_CR6
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2022.12.010
– volume: 11
  start-page: 502
  year: 1990
  ident: 4013_CR24
  publication-title: Hepatology
  doi: 10.1002/hep.1840110324
– volume: 22
  start-page: 1265
  year: 2024
  ident: 4013_CR5
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2024.01.039
– ident: 4013_CR7
– volume: 82
  start-page: 777
  year: 2005
  ident: 4013_CR9
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/82.4.777
– volume: 20
  start-page: 107
  year: 2020
  ident: 4013_CR17
  publication-title: BMC Geriatr
  doi: 10.1186/s12877-020-1501-8
– volume: 404
  start-page: 1053
  year: 2024
  ident: 4013_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(24)01303-5
– volume: 10
  start-page: 3046
  year: 2022
  ident: 4013_CR20
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10123046
– volume: 18
  start-page: 388
  year: 2024
  ident: 4013_CR14
  publication-title: Biosci Trends
  doi: 10.5582/bst.2024.01108
– ident: 4013_CR27
– volume: 21
  start-page: 512
  year: 2023
  ident: 4013_CR10
  publication-title: BMC Med
  doi: 10.1186/s12916-023-03225-7
– volume: 21
  start-page: 5357
  year: 2020
  ident: 4013_CR23
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21155357
– ident: 4013_CR22
  doi: 10.17116/terarkh20178912216-225
– ident: 4013_CR2
– volume: 15
  start-page: 2014
  year: 2023
  ident: 4013_CR28
  publication-title: Nutrients
  doi: 10.3390/nu15092014
– volume: 2021
  start-page: 9151525
  year: 2021
  ident: 4013_CR3
  publication-title: Can J Gastroenterol Hepatol
  doi: 10.1155/2021/9151525
– ident: 4013_CR8
SSID ssj0017823
Score 2.3981345
Snippet Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often associated with...
Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often...
BackgroundPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts, often...
Abstract Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts,...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 421
SubjectTerms Adult
Age
Aged
Bile ducts
Bilirubin
Bilirubin - blood
Biomarkers - blood
Blood cholesterol
Breast cancer
Cholangitis
Cholesterol
Cholesterol - blood
CPNI
Development and progression
Female
Females
Health aspects
Hemoglobin
Hospitals
Humans
Kaplan-Meier Estimate
Liver cirrhosis
Liver Cirrhosis, Biliary - blood
Liver Cirrhosis, Biliary - mortality
Liver diseases
Lymphocytes
Malabsorption
Male
Malnutrition
Measurement
Medical prognosis
Middle Aged
Normal distribution
Nutrition
Nutrition Assessment
Nutritional Status
Obesity
Osteoporosis
Overweight
Patients
Primary biliary cholangitis
Product/Service Evaluations
Prognosis
Proteins
Pruritus
Regression analysis
Retrospective Studies
Risk factors
ROC Curve
Serum albumin
Survival
Thyroid diseases
Vitamins
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV0xa90wEBYhQ8lS2iZtnSbBgUCGICLbkiyNSWgIgXRqIJuQLIk-aG2IX_b89NzJ8uOZDl062VhnI-vufN_h03eEnFkmXKWtp62WgvLacqqlthQiC1dRBM4S8fzDD3n3yO-fxNNWqy-sCZvogaeFu5Qx1DEw6wMLHPsn2agq2XkZGxG8TPvIIebNyVT-fwBxr5m3yCh5OcJXuMViW0EZJhRULcJQYuv_-5u8FZSWBZNbEej2A3mfoWN5NU35I9kJ_Sfy7iH_HN8nrzfY6xaJD4bf9M_gVxHgZYkFWP2AbMxlPzPvw1MSS2Jpx9L26XxqhbveFsed-Vi88wwCcD2xUpRYS4vHlBNjr6PVWGZu1vGAPN5-_3lzR3ODBdqJql1TrrvoIKewWJ2pvK6l7yorImCuIHgDkb7jgXkOkAuBglS-0jpy71ovXLSq-Ux2-6EPX0nJnVLWN62tOgAMjiltHXbMjVK7EKQryMW83ibP2KT8Q0kzaceAdkzSjlEFuUaVbCSRAztdAMsw2TLMvyyjIOeoUIOeClrrbN5wABNGzitzpXgNgKdVoiBHC0nwsG45PJuEyR4-mqaupBCI9gpyuhnGO7FqrQ_DS5JBpgGuQebLZEGbV-IMEmOADwVRC9tavPNypF_9SvzfFcANoZg8_B-r9I3s1ckvBG3YEdldP7-EY8BZa3eSXOoN8HMofA
  priority: 102
  providerName: Directory of Open Access Journals
Title Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients
URI https://www.ncbi.nlm.nih.gov/pubmed/40448036
https://www.proquest.com/docview/3216558937
https://www.proquest.com/docview/3214316497
https://pubmed.ncbi.nlm.nih.gov/PMC12125806
https://doaj.org/article/6fe2fe0ade0e41869af816cd6f35ed67
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fixMxEA56B-KL-NvVs6wg-CDhsrtJNnmS63HHIdwhhwfFl5BsEi3ornZ77_7pzqRp7SL40pbNtGQ7M5lvspNvCHlrmXCVtp62WgrKa8upltpSiCxcRRE4S8Tzl1fy4oZ_XIhF3nAbc1nldk1MC7UfOtwjP27qSgqB0fXDz18Uu0bh09XcQuMuOUTqMizpahe7hKuC6NdsD8ooeTzCWtxiya2gDNMKqibBKHH2_7sy74WmadnkXhw6f0geZABZnmw0_ojcCf1jcu8yPyJ_Qn6fYsdbpD8YvtMfg19GAJkllmH1A3Iyl_2Wfx9-JXEllnYsbZ8-bxrirvfF8Xw-lvCsQACuJ26KEitq8T1lxtjxaDmWmaF1fEpuzs8-n17Q3GaBdqJq15TrLjrILCzWaCqva-m7yooIyCsI3kC873hgngPwQrggla-0jty71gsXrWqekYN-6MMLUnKnlPVNa6sOYINjSluHfXOj1C4E6Qryfvt_mzxjk7IQJc1GOwa0Y5J2jCrIHFWyk0Qm7HRhWH012bGMjKGOgVkfWODYX8tGVcnOy9iI4GVbkHeoUIP-ClrrbD52ABNG5itzongNsKdVoiBHE0nws246vDUJk_18NH-tsiBvdsP4Taxd68Nwm2SQb4BrkHm-saDdLXEG6TGAiIKoiW1N7nk60i-_JRbwCkCHUEy-_P-8XpH7dbJ4QRt2RA7Wq9vwGnDU2s2Ss8zI4fzs6tP1LO1GwOv1_MsfEGQiVw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKKwEXxJtAgSCBOCCrediOfUCoLa22tLtCqJV6M05sw0qQwGYrxI1fxG9kxkmWjZC49bSreDZydsYz38Tjbwh5bhJepspYWijBKcsMo0ooQyGyMOm5Y0kgnp_OxOSMvTvn5xvk93AWBssqB58YHLVtKnxHvpNnqeAco-ubb98pdo3C3dWhhUZnFsfu5w9I2drXR29Bvy-y7PDgdH9C-64CtOJpsaRMVb4EIG2wJFFalQlbpYZ7ABqOsxzCW8VcYhngDIyOQtpUKc9sWVheeiNzuO8VsgWSCTiCrb2D2fsPq30LiLf5cDRHip0WvH-BRb6cJpjIUDkKf6FLwL-xYC0Yjgs11yLf4U1yo4es8W5nY7fIhqtvk6vTflP-Dvm1jz12kXCh-UK_NnbuAdbGWPhVN8gCHdcD4z_cJbAzxqaNTR2-dy14l-viyAiARUMLEIDrgQ0jxhpe_Ay5OPZYmrdxzwnb3iVnl6KCe2Szbmr3gMSslNLYvDBpBUClTKQyJXbq9UKVzokyIq-G_1v3M9Yh75FCd9rRoB0dtKNlRPZQJStJ5N4OF5rFJ90vZS28y7xLjHWJY9jRy3iZisoKn3NnRRGRl6hQjR4CtFaZ_qADTBi5tvSuZBkArULyiGyPJGFlV-PhwSR071la_XcdROTZahh_idVytWsuggwyHDAFMvc7C1o9EksgIQfYEhE5sq3RM49H6vnnwDueAszhMhEP_z-vp-Ta5HR6ok-OZsePyPUsWD-nebJNNpeLC_cYUNyyfNIvnZh8vOzV-gcGC1uU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cholesterol-modified+prognostic+nutritional+index+as+an+independent+prognostic+biomarker+in+primary+biliary+cholangitis+patients&rft.jtitle=BMC+gastroenterology&rft.au=Zhu%2C+Huiling&rft.au=Zheng%2C+Mengyao&rft.au=Li%2C+Wenbin&rft.au=Huang%2C+Yaqin&rft.date=2025-05-30&rft.pub=BioMed+Central+Ltd&rft.issn=1471-230X&rft.eissn=1471-230X&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12876-025-04013-8&rft.externalDocID=A842215785
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon